Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Almassi

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
BJU International|June 17, 2024
Body morphometry may predict parastomal hernia following radical cystectomy with ileal conduitZaeem Lone, David Shin, Amy Nowacki, et al.
The Journal of Urology|March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active SurveillanceYaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
The Journal of Urology|August 10, 2017
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable FeaturesCharles Dai, Vishnu Ganesan, Joseph Zabell, et al.
The Journal of Urology|June 18, 2025
Association Between Midline Extraction Incision and Increased Risk of Incisional Hernia After Minimally Invasive Radical Nephrectomy: Results of an Observational Study From a High-Volume CenterZaeem Lone, Shelby Harper, David Shin, et al.
Urology Practice|February 5, 2024
Changes in the Perioperative Management and Outcomes of Patients With Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 Years of ExperienceWesley Yip, Melissa J Assel, Nathan C Wong, et al.
Cell Reports|December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancerTimothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder CancerEugene J Pietzak, Karissa Whiting, Preethi Srinivasan, et al.
JCO Precision Oncology|June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular PhenotypeNima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Nature Communications|April 26, 2020
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenograftsKwanghee Kim, Wenhuo Hu, François Audenet, et al.
European Urology|November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial CarcinomaKwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
BJU International|June 17, 2024
Body morphometry may predict parastomal hernia following radical cystectomy with ileal conduitZaeem Lone, David Shin, Amy Nowacki, et al.
The Journal of Urology|March 29, 2017
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active SurveillanceYaw A Nyame, Nima Almassi, Samuel C Haywood, et al.
The Journal of Urology|August 10, 2017
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable FeaturesCharles Dai, Vishnu Ganesan, Joseph Zabell, et al.
The Journal of Urology|June 18, 2025
Association Between Midline Extraction Incision and Increased Risk of Incisional Hernia After Minimally Invasive Radical Nephrectomy: Results of an Observational Study From a High-Volume CenterZaeem Lone, Shelby Harper, David Shin, et al.
Urology Practice|February 5, 2024
Changes in the Perioperative Management and Outcomes of Patients With Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 Years of ExperienceWesley Yip, Melissa J Assel, Nathan C Wong, et al.
Cell Reports|December 21, 2022
Genomic heterogeneity as a barrier to precision oncology in urothelial cancerTimothy N Clinton, Ziyu Chen, Hannah Wise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder CancerEugene J Pietzak, Karissa Whiting, Preethi Srinivasan, et al.
JCO Precision Oncology|June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular PhenotypeNima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Nature Communications|April 26, 2020
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenograftsKwanghee Kim, Wenhuo Hu, François Audenet, et al.
European Urology|November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial CarcinomaKwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
Pageof 9